{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:12:16Z","timestamp":1777529536293,"version":"3.51.4"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001202","name":"Gastroenterological Society of Australia","doi-asserted-by":"publisher","award":["Postgraduate Clinical Research Scholarship"],"award-info":[{"award-number":["Postgraduate Clinical Research Scholarship"]}],"id":[{"id":"10.13039\/501100001202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185609","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T18:02:29Z","timestamp":1508868149000},"page":"e0185609","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4764-0799","authenticated-orcid":true,"given":"Swee Lin G.","family":"Chen Yi Mei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Iser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tin","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul V.","family":"Desmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"issue":"1 Suppl","key":"ref1","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"E Gower","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1440-1746.2009.05910.x","article-title":"The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997\u20132006","volume":"24","author":"HF Gidding","year":"2009","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"24","key":"ref3","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"AJ van der Meer","year":"2012","journal-title":"JAMA"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/ajg.2010.294","article-title":"Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response","volume":"105","author":"CM Fern\u00e1ndez-Rodr\u00edguez","year":"2010","journal-title":"The American journal of gastroenterology"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"BJ Veldt","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.23744","article-title":"Outcome of sustained virological responders with histologically advanced chronic hepatitis C","volume":"52","author":"TR Morgan","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2009.12.028","article-title":"Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis","volume":"52","author":"AC Cardoso","year":"2010","journal-title":"Journal of Hepatology"},{"issue":"5","key":"ref8","first-page":"1303","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"T Poynard","year":"2002","journal-title":"YGAST"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/hep.20073","article-title":"Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data","volume":"39","author":"C Camm\u00e0","year":"2004","journal-title":"Hepatology"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/cir076","article-title":"Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more","volume":"52","author":"BLB Pearlman","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"P Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"L Cast e ra","year":"2005","journal-title":"Gastroenterology"},{"issue":"42","key":"ref13","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.3748\/wjg.14.6513","article-title":"Comparison of the liver stiffness measurement by transient elastography with the liver biopsy","volume":"14","author":"I Sporea","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2893.2011.01534.x","article-title":"Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(<sup>\u00ae<\/sup>): validation in chronic hepatitis C","volume":"19","author":"M Sasso","year":"2012","journal-title":"J Viral Hepat"},{"issue":"2","key":"ref15","first-page":"155","article-title":"Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients","volume":"17","author":"M Lup\u015for","year":"2008","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"M Ziol","year":"2005","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2893.2009.01210.x","article-title":"Prospective comparison of Fibroscan, King&apos;s score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection","volume":"17","author":"TJS Cross","year":"2010","journal-title":"J Viral Hepat"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00535-009-0017-y","article-title":"FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis","volume":"44","author":"J-H Wang","year":"2008","journal-title":"J Gastroenterol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2013-305357","article-title":"Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters","volume":"64","author":"AJ van der Meer","year":"2015","journal-title":"Gut"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/apt.13472","article-title":"Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C","volume":"43","author":"S Lens","year":"2016","journal-title":"Alimentary pharmacology \\& therapeutics"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"AJ Freeman","year":"2001","journal-title":"Hepatology (Baltimore, Md). W.B. Saunders"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jclinepi.2005.06.008","article-title":"Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment","volume":"59","author":"MJ Sweeting","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep.510310236","article-title":"Which patients with hepatitis C develop liver complications?","volume":"31","author":"MH Khan","year":"2000","journal-title":"Hepatology (Baltimore, Md). W.B. Saunders"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.510270637","article-title":"Role of alcohol in the progression of liver disease caused by hepatitis C virus infection","volume":"27","author":"G Ostapowicz","year":"1998","journal-title":"Hepatology (Baltimore, Md). W.B. Saunders"},{"issue":"9055","key":"ref25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"T Poynard","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/hep.510280330","article-title":"Impact of alcohol on the histological and clinical progression of hepatitis C infection","volume":"28","author":"TE Wiley","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hep.20127","article-title":"Risks of a range of alcohol intake on hepatitis C-related fibrosis","volume":"39","author":"A Monto","year":"2004","journal-title":"Hepatology (Baltimore, Md). Wiley Subscription Services, Inc., A Wiley Company"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.20733","article-title":"Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C","volume":"42","author":"C Hezode","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.23279","article-title":"Increased caffeine consumption is associated with reduced hepatic fibrosis","volume":"51","author":"AA Modi","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref30","article-title":"Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C","author":"U Arena","year":"2008","journal-title":"Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:42:56Z","timestamp":1588988576000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185609"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185609","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}